Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study

术前血小板白蛋白比值联合癌症炎症预后指数可预测结直肠癌预后:一项回顾性研究

阅读:2

Abstract

Colorectal cancer (CRC) has one of the highest incidence and mortality rates of any cancer worldwide, and the recurrence and metastasis rates after surgery remain high. The search for simple and reliable prognostic markers is essential to improve patient prognosis. In this study, we investigated the predictive value of two easy-to-measure preoperative markers, platelet-to-albumin ratio (PAR) and cancer inflammation prognostic index (CIPI), in postoperative survival of patients with CRC. We retrospectively analyzed the clinical data of a total of 434 CRC patients from two hospitals. Data from one of the institutions were used as a training cohort. The predictive ability of both markers was assessed using subject work characteristics (ROC) curves, with optimal cutoff values of 11.69 and 6.85 for CIPI and PAR, respectively, and high CIPI and PAR were independently associated with poorer overall survival. We developed nomogram of overall survival (OS), performed internal and external validation, and showed superior prognostic accuracy of the nomogram models. Our results suggest that combined CIPI and PAR can be used as a valid and accessible prognostic tool that is expected to help develop personalized treatment strategies for CRC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。